Clinical Trials Logo

Clinical Trial Summary

This study aims to investigate the effectiveness of Lactobacillus reuteri DSM17938 supplementation on infantile colic in Indonesian infants.


Clinical Trial Description

Infantile colic is a problem faced by many parents and caregivers. There is no evidence that medications does help in this situation. The etiology of infantile colic is still unknown. Lactobacillus reuteri has been shown in five studies to reduce crying time in infants diagnosed with infantile colic. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03106285
Study type Interventional
Source BioGaia AB
Contact
Status Withdrawn
Phase N/A
Start date April 14, 2017
Completion date July 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT03219931 - NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants Phase 4
Completed NCT03434249 - Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic N/A
Active, not recruiting NCT05363553 - Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study N/A
Recruiting NCT06031025 - Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
Recruiting NCT03155360 - Infants Colics : Towards a Migrainous Origin ? N/A
Completed NCT03675763 - Efficacy of a Craniosacral Therapy Protocol in the Treatment of Infant Colic N/A
Recruiting NCT05512234 - Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic N/A
Recruiting NCT05894798 - Acupuncture in Infantile Colic - A Randomised Trial. N/A
Recruiting NCT04841590 - Effects of Osteopathic Manual Therapy on Infant Colic N/A